Showing 1 - 10 of 862
Looking at how well drugs work in routine clinical practice, rather than only in experimental randomised controlled clinical trials (RCTs), is increasingly seen as essential for a proper assessment of both net benefit (health gain minus harm and value (net benefit minus net cost). Establishing...
Persistent link: https://www.econbiz.de/10013018440
Background: Market authorization does not guarantee patient access to any given drug. This is particularly true for costly orphan drugs because access depends primarily on co-payments, reimbursement policies and prices. The objective of this article is to identify differences in the availability...
Persistent link: https://www.econbiz.de/10014185808
Persistent link: https://www.econbiz.de/10000159763
Persistent link: https://www.econbiz.de/10012129338
Persistent link: https://www.econbiz.de/10010442090
Today, increases in the demand for healthcare are driving European governments to look for ways to control growth in healthcare expenditures and at the same time improve health outcomes. Consideration of ways to enhance trade in healthcare goods and services is important for governments as they...
Persistent link: https://www.econbiz.de/10011290803
Persistent link: https://www.econbiz.de/10011705815
"This book explores the influence of justice principles in the field of health care law. By examining the role played by key stakeholders, it tracks the evolution of distributive norms for the allocation of healthcare resources in western welfare states. The issue of justice in the field of...
Persistent link: https://www.econbiz.de/10011971572
Rights -- Equality -- Needs -- Outcomes -- Technology -- Quality -- Costs -- Efficiency -- Unnecessary care -- Administrative costs -- Priorities -- Prevention -- Managed care -- International competitiveness -- The elderly -- Minorities -- Rural areas -- Prescription drugs -- Public opinion --...
Persistent link: https://www.econbiz.de/10001981926
Wie funktioniert Gesundheitspolitik anderswo und warum? Seit März 2003 berichten Experten aus sechzehn Industrieländern … zweimal jährlich zu aktuellen Entwicklungen in der Gesundheitspolitik. Schwerpunkte des vorliegenden zweiten Reports … "Gesundheitspolitik in Industrieländern" (Zeitraum März bis Oktober 2003) sind die gesundheitspolitischen Herausforderungen des …
Persistent link: https://www.econbiz.de/10001959637